ARCHIVES

NCAB Oks Organ Systems Plan, Criteria For Starting, Ending Working Groups

This article is from The Cancer Letter archive.

Vol. 14 No. 39 | October 7, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Grants Accelerated Approval to Imbruvica

November 29, 2013

Recombinant TSH Avoids Need To Stop Replacement Therapy

January 27, 2006

In Brief: Terry To Leave NCI for Job As VP Of Revlon Health Care Group; NCI Tracking Source Of Breakthroughs

June 18, 1982

In Congress: Time Running out On Effort To Double Market Exclusivity Term

November 7, 1997

Immune Therapy Possible For Metastatic Breast Cancer

September 24, 2004

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

June 16, 1999